Clion Clinica de Oncologia
Clion Clinica de Oncologia, now Oncoclínicas Rio Vermelho, is a Salvador, Bahia-based oncology clinic within publicly traded Oncoclínicas&Co, delivering multidisciplinary cancer care and precision medicine diagnostics to oncology patients in the Bahia region.
- Company typePublic
- Founded2019
- HeadquartersSalvador, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Clion Clinica de Oncologia does
Clion Clinica de Oncologia, operating as Oncoclínicas Rio Vermelho, is a single-site oncology clinic located in the Rio Vermelho neighborhood of Salvador, Bahia, Brazil. Founded in 2019 and integrated into the publicly traded Oncoclínicas&Co group (B3: ONCO3) the same year, the unit operates across two floors with 20 consultation rooms and delivers multidisciplinary cancer care spanning chemotherapy, radiotherapy, immunotherapy, targeted therapy, cell therapy, bone marrow transplant, oncological surgery, hormonal therapy, and palliative care, including pediatric oncology via Oncopediatria.
The unit's core technical differentiator is its access to Oncoclínicas' OC Medicina de Precisão platform, which provides molecular diagnostics, genetic testing, pathological analysis, the proprietary Onco-PDO personalized drug sensitivity test, and the Jornada Molecular diagnostic pathway. These capabilities are paired with clinical research and trial enrollment through a core strategic alliance with Instituto Oncoclínicas, alongside a support stack covering psychology, nutrition, physiotherapy, nursing, palliative care, patient navigation (OC Navegação), telemedicine, and integrative medicine.
Revenue is generated through direct fee-for-service patient care, paid via Brazilian health insurance plans (convenios) or private pay, with additional patient acquisition driven by an external physician referral portal, the OC Academia medical education network, the Oncoclínicas mobile app, and group-level digital marketing. Pricing is not publicly disclosed and contracts are negotiated treatment-by-treatment.
Clion Clinica de Oncologia firmographics
Firmographics- Name
- Clion Clinica de Oncologia
- Legal name
- ONCOCLINICAS DO BRASIL SERV MEDICOS SA
- Website
- https://clion.com.br
- Company type
- Public
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clion Clinica de Oncologia, now Oncoclínicas Rio Vermelho, is a Salvador, Bahia-based oncology clinic within publicly traded Oncoclínicas&Co, delivering multidisciplinary cancer care and precision medicine diagnostics to oncology patients in the Bahia region.
- Ownership category
- akta.pro rank
Clion Clinica de Oncologia industry classification
Industry- Product category
- Oncology Healthcare Services
- NAICS
- Ambulatory Health Care Services (621), Medical Laboratories (621511), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where Clion Clinica de Oncologia is headquartered
LocationHeadquarters
- HQ city
- Salvador
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Clion Clinica de Oncologia business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Clinical Oncology Services: Direct patient care services including consultations, chemotherapy, radiotherapy, immunotherapy, targeted therapy, surgeries, and bone marrow transplants. Revenue generated through health insurance agreements (convenios) and private payments.
- Diagnostic Services: Pathological analysis, genetic testing, molecular diagnostics, and specialized tests including Onco-PDO. Integrated into patient treatment pathways.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Clion Clinica de Oncologia product offering
Product offeringCore offering
Clion Clinica de Oncologia (operating as Oncoclínicas Rio Vermelho) is a Salvador-based oncology clinic delivering comprehensive cancer diagnosis, treatment, and supportive care. Services include chemotherapy, radiotherapy, immunotherapy, targeted therapy, cell therapy, bone marrow transplant, oncological surgery, hormonal therapy, pediatric oncology, and palliative care. The clinic integrates precision medicine diagnostics (OC Medicina de Precisão, Onco-PDO test, genetic testing, molecular journey) and is part of the publicly traded Oncoclínicas&Co network.
Product overview
Clion Clinica de Oncologia (now Oncoclínicas Rio Vermelho) is an oncology clinic offering a comprehensive range of cancer treatment and diagnostic services. The clinic provides multiple treatment modalities including chemotherapy, radiotherapy, immunotherapy, targeted therapy, cell therapy, and bone marrow transplant. Diagnostic services include precision medicine, pathological analysis, genetic testing, and molecular journey programs. Support services encompass palliative care, patient navigation, survivorship programs, telemedicine, and integrative medicine. The clinic operates as part of the Oncoclínicas group network, providing multidisciplinary humanized oncology care.
Differentiator
Problem solved
Functional benefit
Products and services
- Chemotherapy (Quimioterapia) Chemotherapy treatment service delivered to oncology patients as part of the clinic's multidisciplinary cancer care program.
- Radiotherapy (Radioterapia) Radiotherapy treatment service for cancer patients provided at the Rio Vermelho unit.
- Oncological Surgery (Cirurgias Oncológicas) Surgical oncology services covering head and neck, thoracic, and coloproctology procedures.
- Immunotherapy (Imunoterapia) Immunotherapy treatment service for cancer patients, including infusion center delivery.
- Targeted Therapy (Terapia-alvo) Targeted therapy treatment tailored to specific cancer types and molecular profiles.
- Cell Therapy (Terapia Celular) Cell therapy treatment service for oncology patients.
- Bone Marrow Transplant (Transplante de Medula Óssea) Bone marrow transplant service for hematological and other oncology indications.
- Hormonal Therapy (Hormonioterapia) Hormonal therapy treatment for hormone-responsive cancers.
- Pediatric Oncology (Oncopediatria) Specialized oncology services for children with cancer.
- OC Precision Medicine (OC Medicina de Precisão) Precision medicine diagnostic service offering molecular diagnostics, genetic testing, pathological analysis, and individualized treatment protocol design.
- Pathological Analysis (Análise Patológica) Pathological analysis service used for cancer diagnosis.
- Genetic Testing (Testes Genéticos) Genetic testing services for cancer risk assessment and treatment planning.
- Onco-PDO Test (Teste Onco-PDO) Personalized drug sensitivity testing that guides individualized oncology treatment selection.
- Molecular Journey (Jornada Molecular) Comprehensive molecular profiling pathway that supports diagnosis and treatment selection for oncology patients.
- Myelogram (Mielograma) Myelogram and bone marrow biopsy diagnostic service.
- Palliative Care (Cuidados Paliativos) Palliative care services supporting cancer patients through symptom management and quality-of-life care.
- OC Navegação (Patient Navigation) Patient navigation service guiding oncology patients through their treatment journey.
- Survivorship Program (Survivorship) Post-treatment survivorship program for cancer patients.
- Integrative Medicine (Medicina Integrativa) Integrative medicine combining conventional oncology care with complementary approaches.
- DeLife Program Support program for cancer patients.
- OC Estomatology (OC Estomatologia) Stomatology services for oncology patients.
- Telemedicine (Telemedicina) Telemedicine consultation services for remote patient care and follow-up.
- Clinical Research (Pesquisa Clínica) Clinical research program developing and evaluating new oncology treatments, with access via the Oncoclínicas network.
Companies that use Clion Clinica de Oncologia
Customer profileSegments1 record
Ideal customer profiles1 record
Clion Clinica de Oncologia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Clion Clinica de Oncologia partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Instituto OncoclínicascoreResearch and education institute affiliated with Oncoclínicas group. Conducts clinical research, publishes scientific studies, and supports medical education. The Rio Vermelho unit has access to clinical trials and research programs through this partnership.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Clion Clinica de Oncologia competitors and assessment
Company assessmentDirect peers
- Hospital de Amor: Major Brazilian oncology hospital network (formerly Hospital do Câncer de Barretos). Directly comparable as a comprehensive Brazilian cancer center providing multi-modality oncology care across prevention, treatment, and research — overlapping with Clion's service mix and patient base.
- Instituto do Câncer do Estado de São Paulo (ICESP): Public Brazilian cancer institute offering comprehensive oncology services including chemotherapy, radiotherapy, surgery, and research. Directly comparable in clinical scope and precision diagnostics focus, though primarily public-pay.
- A.C. Camargo Cancer Center: Premier Brazilian oncology hospital and research institution based in São Paulo. Comparable as a comprehensive cancer center offering medical oncology, surgical oncology, radiation, precision diagnostics, and clinical research — directly competing for complex oncology cases and specialist talent.
Others
- DASA (Diagnósticos da América): Brazil's largest diagnostics company offering imaging, lab, and molecular testing including oncology. Comparable as a supporting infrastructure provider for Clion's precision medicine workflow — a potential partner or competitor in molecular diagnostics.
Broad incumbents
- Rede D'Or São Luiz: Brazil's largest private hospital network with oncology service lines across multiple units. Comparable as a multi-site oncology provider operating under similar insurance reimbursement dynamics and competing for private-pay oncology volumes.
- Hospital Sírio-Libanês: Large Brazilian private hospital with a strong oncology program. Comparable as a high-end private payer provider of multi-modality cancer care (medical, surgical, radiation) with research affiliations — competes for the same premium oncology patients and insurance contracts.
- Hospital Israelita Albert Einstein: Top-tier Brazilian private hospital with a well-established oncology center. Comparable as a premium multi-specialty provider offering comprehensive cancer care, clinical trials, and precision medicine — overlaps significantly in payer mix and patient demographic.
- Beneficência Portuguesa de São Paulo (BP): Large Brazilian private hospital system with a substantial oncology service line. Comparable as a multi-specialty provider delivering medical and surgical oncology across ambulatory and inpatient settings — competes for insurance contracts and complex case referrals.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Clion Clinica de Oncologia social profiles
Digital presenceClion Clinica de Oncologia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clion Clinica de Oncologia leadership team
Management profileNumber of profiles
Profiles2 records
Clion Clinica de Oncologia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clion Clinica de Oncologia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clion Clinica de Oncologia
What does Clion Clinica de Oncologia do?
Clion Clinica de Oncologia (operating as Oncoclínicas Rio Vermelho) is a Salvador-based oncology clinic delivering comprehensive cancer diagnosis, treatment, and supportive care. Services include chemotherapy, radiotherapy, immunotherapy, targeted therapy, cell therapy, bone marrow transplant, oncological surgery, hormonal therapy, pediatric oncology, and palliative care. The clinic integrates precision medicine diagnostics (OC Medicina de Precisão, Onco-PDO test, genetic testing, molecular journey) and is part of the publicly traded Oncoclínicas&Co network.
Is Clion Clinica de Oncologia a public or private company?
Clion Clinica de Oncologia is a public company. It is classified as corporate owned and is currently operating.
When was Clion Clinica de Oncologia founded?
Clion Clinica de Oncologia was founded in 2019. It employs 11 to 50 people.
Where is Clion Clinica de Oncologia based?
Clion Clinica de Oncologia is headquartered in Salvador, Brazil, in the Latin America region.
How does Clion Clinica de Oncologia make money?
Two revenue lines are on record. Clinical Oncology Services are the primary driver. The others are diagnostic Services.
Who are Clion Clinica de Oncologia's main competitors?
Direct peers on record are Hospital de Amor, Instituto do Câncer do Estado de São Paulo (ICESP) and A.C. Camargo Cancer Center. DASA (Diagnósticos da América) is listed as an others. Broad incumbents are Rede D'Or São Luiz, Hospital Sírio-Libanês, Hospital Israelita Albert Einstein and Beneficência Portuguesa de São Paulo (BP).
Does Clion Clinica de Oncologia have an API?
No public API is recorded for Clion Clinica de Oncologia.
What industry is Clion Clinica de Oncologia in?
Clion Clinica de Oncologia's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 621 and its SIC code is 8011.